EUVIMEDEUVIMED entdecken
Crossref

Effect of Tolyl Modification on Celecoxib Related Structure: Molecular Features of MMP-interacting UTX-121 Derivatives

Kazuto Ohkura, Atsushi Tabata, Yoshihiro Uto

Anticancer Research · 2026-08 · 46 (8) · 4639-4647

DOI: 10.21873/anticanres.18321 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 29.07.2026. Verfasst von Kazuto Ohkura und 2 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Japan; kohkura@suzuka-u.ac.jp. Hauptthemen laut MEDLINE: Celecoxib, Matrix Metalloproteinase Inhibitors, Antineoplastic Agents, Matrix Metalloproteinases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Matrix metalloproteinases (MMPs) are important enzymes in extracellular matrix degradation. Several cancer types overexpress MMPs, indicating that MMP inhibition may be a viable approach to induce antitumor activity. To explore this, we designed UTX-121, a molecule in which the sulfonamide group of celecoxib is replaced with a methyl ester group. From this structure, a range of UTX-121 derivatives were developed in which the tolyl moiety was modified. The MMP inhibitory effects of these derivatives were then examined. MATERIALS AND METHODS: ) were examined using the WST-8 assay. MMP inhibition in HT-1080 cells by UTX-121 derivatives was evaluated by gelatin zymography. UTX-121 derivative conformational analysis was performed using CAChe-Conflex (Fujitsu Inc., Tokyo, Japan). MMP interactions with UTX-121 derivatives were analyzed by Molegro Virtual Docker (CLC bio., Aarhus, Denmark). RESULTS: The antitumor activities of UTX-121 derivatives b1-b3, b8, and b11 were greater than those of UTX-121. Derivatives b1-b3, b8, and b11 yielded greater MMP-9 inhibition than UTX-121. Derivatives b1-b3 also inhibited MMP-2. Modelling indicated that derivatives b1-b3, b8, and b11 bound to the MMP-9 enzyme, mediated by a hydrogen bond. Derivatives b1-b3 also bound to MMP-2. CONCLUSION: Derivatives b1-b3, which regulate both MMP-9 and MMP-2 function, appear to have structural features associated with broader MMP interactions. In contrast, MMP-9-specific probes may be developed using the structural features of derivatives b8 and b11.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CelecoxibMatrix Metalloproteinase InhibitorsAntineoplastic AgentsMatrix MetalloproteinasesHumansCell Line, TumorStructure-Activity RelationshipMolecular Docking Simulation

Stichwörter der Autor:innen

MMPMolecular designUTX-121celecoxibstructure

Substanzen

CelecoxibMatrix Metalloproteinase InhibitorsAntineoplastic AgentsMatrix Metalloproteinases

Autor:innen und Institutionen

  • Graduate School of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Japan; kohkura@suzuka-u.ac.jp.
  • Department of Bioengineering, Division of Bioscience and Bioindustry, Graduate School of Technology, Industrial and Social Sciences, Tokushima University Graduate School, Tokushima, Japan.

Zitieren

APA

Ohkura, K., Tabata, A., & Uto, Y. (2026). Effect of Tolyl Modification on Celecoxib Related Structure: Molecular Features of MMP-interacting UTX-121 Derivatives. Anticancer Research, 46(8), 4639-4647. https://doi.org/10.21873/anticanres.18321

Vancouver

Ohkura K, Tabata A, Uto Y. Effect of Tolyl Modification on Celecoxib Related Structure: Molecular Features of MMP-interacting UTX-121 Derivatives. Anticancer Research. 2026;46(8):4639-4647. doi:10.21873/anticanres.18321

BibTeX
@article{Ohkura2026,
  author = {Ohkura, Kazuto and Tabata, Atsushi and Uto, Yoshihiro},
  title = {Effect of Tolyl Modification on Celecoxib Related Structure: Molecular Features of MMP-interacting UTX-121 Derivatives},
  journal = {Anticancer Research},
  year = {2026},
  volume = {46},
  number = {8},
  pages = {4639--4647},
  doi = {10.21873/anticanres.18321}
}
Kostenlos starten →